| NCT ID | NCT07132034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Isabell Xiang Ge |
| Condition | Acupuncture |
| Study Type | INTERVENTIONAL |
| Enrollment | 112 participants |
| Start Date | 2026-07-07 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 112 participants in total. It began in 2026-07-07 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial evaluates whether eight weeks of weekly acupuncture can reduce psychological distress in breast cancer patients who have recently completed primary therapy compared to standard-of-care wait-list control.
Eligibility Criteria
Inclusion criteria: * Patients with localized breast cancer having completed primary therapy (operation +/- chemotherapy +/- radiotherapy) in the last 6 months - Distress Thermometer ≥ 5 - Age ≥ 18 years - Signed informed consent for participation of the trial * Prior cancer is allowed * Prior treatment - including chemotherapy - for a prior malignant tumor (including breast cancer) is allowed * Concomitant participation in an experimental therapeutic drug trial is allowed * Ongoing or planned Anti-her2/neu, immune checkpoint inhibitor, antihormonal and CDK4/6 inhibitor therapy or other adjuvant treatment scheduled for \> 3 months during study period is allowed * Use of other complementary methods (including mistletoe) is allowed. Exclusion criteria: * Patients with language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study * Severe physical or psychiatric comorbidity that prevents a patient from participating in the study * Patients incapable of giving consent * Pregnancy
Contact & Investigator
Viola Heinzelmann-Schwarz, Prof.MD
STUDY CHAIR
University Hospital of Basel
Frequently Asked Questions
Who can join the NCT07132034 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Acupuncture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07132034 currently recruiting?
Yes, NCT07132034 is actively recruiting participants. Contact the research team at isabellxiang.ge@usb.ch for enrollment information.
Where is the NCT07132034 trial being conducted?
This trial is being conducted at Basel, Switzerland, Rheinfelden, Switzerland, Thun, Switzerland.
Who is sponsoring the NCT07132034 clinical trial?
NCT07132034 is sponsored by Isabell Xiang Ge. The principal investigator is Viola Heinzelmann-Schwarz, Prof.MD at University Hospital of Basel. The trial plans to enroll 112 participants.